PinnedThe ideal platform to fight a silent pandemicReflecting on Lumen’s new collaboration with Novo NordiskJun 16, 2021Jun 16, 2021
Preventive Biologics May Aid the Antibiotic Resistance CrisisBy: Brian Finrow, JD | First published November 7, 2024 in Pharmacy Times.5d ago5d ago
Clinical Development of Preventive AntimicrobialsBy: Brian Finrow, JD | First published June 13, 2024 in Clinical Researcher.5d ago5d ago
Preventive drugs may be the best solution to the antibiotic resistance crisisBy Brian Finrow│This piece was originally published at STAT NEWS on October 18, 2023Nov 9, 2023Nov 9, 2023
COVID drugs come in 3 flavors; it’s time for more diversityBy Brian Finrow │This piece was originally published at Drug Discovery & Development on October 12th, 2021Mar 23, 2023Mar 23, 2023
Drug developers navigating ‘biology’s century’ need a model. We made oneBy Brian Finrow, Aleks Engel and Srinivas Akkaraju │This piece was originally published at STAT NEWS on March 15th, 2023Mar 20, 2023Mar 20, 2023
Moving closer to the patientThoughts on the journey from bench to bedside for patients at risk of C. difficile infectionApr 18, 2022Apr 18, 2022
‘You can’t get there from here:’ Birth of a biotech platformLumen’s new paper in Nature Biotechnology describes how it harnessed spirulina as a factory and delivery vehicle for oral protein…Mar 23, 2022Mar 23, 2022
Intranasal passive vaccines: thinking beyond the jabThoughts on Lumen’s new collaboration to fight flu with inhaled antibodiesFeb 1, 2022Feb 1, 2022
